Are you Dr. Afif?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Connect with colleagues in the same hospital or clinic
You already have 6 invites waiting! - Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
200 1st St Sw
Rochester, MN 55905Phone+1 507-284-2511- Is this information wrong?
Summary
- Dr. Waqqas Afif, MD is a gastroenterologist in Rochester, Minnesota. He is affiliated with Mayo Clinic Hospital - Rochester.
Clinical Trials
- TDM Guided Early Optimization of ADAL in Crohn's Disease Start of enrollment: 2017 Jan 17
Publications & Presentations
PubMed
- 1 citationsAdherence to Objective Therapeutic Monitoring and Outcomes in Patients with Inflammatory Bowel Disease with Adalimumab Treatment. A Real-world Prospective Study.Panu Wetwittayakhlang, Petra A Golovics, Alex Al Khoury, Elie Ganni, Gustavo Drügg Hahn, Albert Cohen, Jonathan Wyse, Marc Bradette, Talat Bessissow, Waqqas Afif, Gary...> ;Journal of Gastrointestinal and Liver Diseases. 2022 Dec 16
- 8 citationsThe present and future of gastroenterology and hepatology: an international SWOT analysis (the GASTROSWOT project).Enrique de-Madaria, José J Mira, Irene Carrillo, Waqqas Afif, Daphne Ang, Marina Antelo, Steven Bollipo, Antoni Castells, Prabhleen Chahal, Henriette Heinrich, Joanna ...> ;The Lancet. Gastroenterology & Hepatology. 2022 May 1
- 12 citationsEarly Symptomatic Improvement After Ustekinumab Therapy in Patients With Ulcerative Colitis: 16-Week Data From the UNIFI Trial.Silvio Danese, Bruce E Sands, Maria T Abreu, Christopher D O'Brien, Ivana Bravatà, Maciej Nazar, Ye Miao, Yanli Wang, David Rowbotham, Rupert W L Leong, Ramesh P Arasa...> ;Clinical Gastroenterology and Hepatology. 2022 Dec 1
- Join now to see all
Press Mentions
- New STELARA® (Ustekinumab) Long-Term Data Support Its Established Safety Profile in Inflammatory Bowel Disease and Durable Efficacy in Ulcerative ColitisMarch 4th, 2023
- VIDEO: Stelara Safe, Effective for the Long-Term Treatment of Moderate to Severe UCOctober 21st, 2022
- Janssen Touts Positive Mid-Late Stage Data from Two Ulcerative Colitis TrialsOctober 10th, 2022
- Join now to see all
Hospital Affiliations
- Mayo Clinic Hospital - RochesterRochester, Minnesota